Notably, aloin has been shown to play a role in NASH treatment in a mouse model via the activation of the nuclear factor erythroid 2-related factor/heme oxygenase-1 (Nrf2/HO-1) signaling pathway [46,47]. This evidence concerns the gene HMOX1 and metabolic dysfunction-associated steatohepatitis.